VSK Kerala
  • Home
  • വാര്‍ത്ത
    • കേരളം
    • ഭാരതം
    • ലോകം
    • സംഘ വാര്‍ത്തകള്‍
    • സേവന വാര്‍ത്തകള്‍
    • അമൃതമഹോത്സവം
    • ബുള്ളറ്റിൻ
  • English
    • Articles
    • Kerala
    • India
    • World
    • RSS in News
    • Seva News
    • Amrit Mahotsav
  • ലേഖനങ്ങള്‍
  • സംസ്കൃതി
  • വീഡിയോ
  • RSS
    • RSS: Vision and Mission
    • Press Release
    • Resolutions
  • VSK
    • About Us
    • Activities
No Result
View All Result
VSK Kerala
  • Home
  • വാര്‍ത്ത
    • കേരളം
    • ഭാരതം
    • ലോകം
    • സംഘ വാര്‍ത്തകള്‍
    • സേവന വാര്‍ത്തകള്‍
    • അമൃതമഹോത്സവം
    • ബുള്ളറ്റിൻ
  • English
    • Articles
    • Kerala
    • India
    • World
    • RSS in News
    • Seva News
    • Amrit Mahotsav
  • ലേഖനങ്ങള്‍
  • സംസ്കൃതി
  • വീഡിയോ
  • RSS
    • RSS: Vision and Mission
    • Press Release
    • Resolutions
  • VSK
    • About Us
    • Activities
No Result
View All Result
VSK Kerala
No Result
View All Result
Home English

Bharat Biotech’s Covaxin found 81% effective in interim phase 3 trials

Covaxin is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

VSK Kerala Desk by VSK Kerala Desk
4 March, 2021
in English
ShareTweetSendTelegram

Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of its BBV152 (COVAXIN).

It is India’s first COVID-19 Vaccine which demonstrated interim clinical efficacy of 81%. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research.

The Phase 3 study enrolled 25,800 participants between 18-98 years of age, including 2,433 over the age of 60 and 4,500 with comorbidities.

“Today is an important milestone in vaccine discovery, for science and our fight against #coronavirus. With today’s results from our Phase 3 clinical trials, we have now reported data on our COVID-19 vaccine from Phase 1, 2, and 3 trials involving around 27,000 participants. COVAXIN demonstrates high clinical efficacy trend against COVID-19, but also significant immunogenicity against the rapidly emerging variants,” said Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech.

BBV152 contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells. It is stable at 2 to 8°C (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.

BBV152 has a 28-day open vial policy as a unique product characteristic, thus reducing vaccine wastage by approximately 10-30%.

ShareTweetSendShareShare

Latest from this Category

Islamic extremists disrupt International Yoga Day event in Maldives

There Has Been Deliberate Attempt To Discredit Judiciary: Justice N. Nagaresh On Contemptuous Remarks By PFI Leader

‘One Nation – One Health System is the need of Hour’

Father of minor boy who called for genocide of Hindus and Christians in PFI rally arrested

Strict action should be taken against the organizers of the rally – Kerala High Court

Temples vandalised by miscreants in Guwahati ; Shiva, Ganesha idols uprooted and thrown out of Temple

Load More

Discussion about this post

Latest News

Islamic extremists disrupt International Yoga Day event in Maldives

There Has Been Deliberate Attempt To Discredit Judiciary: Justice N. Nagaresh On Contemptuous Remarks By PFI Leader

‘One Nation – One Health System is the need of Hour’

Father of minor boy who called for genocide of Hindus and Christians in PFI rally arrested

Strict action should be taken against the organizers of the rally – Kerala High Court

Temples vandalised by miscreants in Guwahati ; Shiva, Ganesha idols uprooted and thrown out of Temple

Islamic terrorist Yasin Malik sentenced to life imprisonment in terror funding case

Gyanvapi Case – Fresh plea challenging Places of Worship Act filed in Supreme Court

Load More

Latest Malayalam News

ആകാശത്ത് വിസ്മയമായി അഞ്ച് ഗ്രഹങ്ങളുടെ സംഗമം

തമിഴ്നാട്ടിൽ വീണ്ടും ക്ഷേത്രങ്ങൾക്കുനേരെ ആക്രമണം: വിഗ്രഹങ്ങൾ തകർത്തു

മുംബൈയിൽ ഗുരുകുലം വിദ്യാർത്ഥികൾ ദ്രൗപദീമുർമൂവിന് പിന്തുണയുമായി ചിത്രങ്ങൾ വരയ്ക്കുന്നു

ദ്രൗപദീ മുർമൂ: ആവേശത്തോടെ യുവാക്കളും

നാമനിർദേശപത്രിക സമർപ്പിക്കാൻ ഒപ്പം ബിജെഡി മന്ത്രിമാരും

Load More

©Vishwa Samvada Kendram, Kerala.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • വാര്‍ത്ത
    • കേരളം
    • ഭാരതം
    • ലോകം
    • സംഘ വാര്‍ത്തകള്‍
    • സേവന വാര്‍ത്തകള്‍
    • അമൃതമഹോത്സവം
    • ബുള്ളറ്റിൻ
  • English
    • Articles
    • Kerala
    • India
    • World
    • RSS in News
    • Seva News
    • Amrit Mahotsav
  • ലേഖനങ്ങള്‍
  • സംസ്കൃതി
  • വീഡിയോ
  • RSS
    • RSS: Vision and Mission
    • Press Release
    • Resolutions
  • VSK
    • About Us
    • Activities

©Vishwa Samvada Kendram, Kerala.
Tech-enabled by Ananthapuri Technologies